Turn Therapeutics Inc. Common Stock (TTRX) — Cash Flow Quality Index

Latest as of December 2025: -4.21x

Turn Therapeutics Inc. Common Stock (TTRX) has a Cash Flow Quality Index of -4.21x as of December 2025. Operating cash flow of $-1.18 Million is below net income of $279.07K, suggesting accrual-heavy earnings not yet converted to cash. Explore Turn Therapeutics Inc. Common Stock (TTRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.21x

Operating CF / Net Income

Operating Cash Flow

$-1.18 Million

USD

Net Income

$279.07K

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Turn Therapeutics Inc. Common Stock (None–None)

Year-by-year earnings quality comparison for Turn Therapeutics Inc. Common Stock.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.